Case Reports

WOMAN WITH POLYURIA AND POLYDIPSIA
Jeffrey Clough, MSIV, and Andrew Rose, MD
Case Presentation
A 20 year-old Caucasian female with a past medical history
significant only for occasional headaches and anemia presents with
a chief complaint of increasing thirst for two weeks. The patient
was in her usual state of health until approximately two weeks
prior to admission when she noted the gradual onset of increasing
thirst and began drinking more and more water over the next few
days. Her thirst increased to the point where she drank an
estimated 18 liters of fluid during the 24 hours prior to admission.
This thirst was accompanied by frequent urination, which would
often awaken her during the night and she noted her urine to be
very clear. These symptoms began within a few days of a vaginal
yeast infection, for which she was treated with one dose of
fluconazole. She denied any other symptoms during this episode.
Her past medical history was significant for occasional non-focal
headaches without aura or specific precipitants. These headaches
had been present for several years and responded well to NSAIDS.
She also reports that she has a history of anemia and occasionally
takes iron supplements. She does not report taking regular
medications and has never had surgery. Her last menstrual period
was approximately three weeks earlier. She is a college student,
works part-time in a pharmacy and lives with her family and
claims to be happy with her life. She is in a monogamous
relationship with her boyfriend and reports no problems. She
denies alcohol, cigarette, or illicit substance use. Her family
history is significant only for hypertension, diabetes mellitus, and
stroke on her maternal side and gastric cancer in her maternal
grandfather. She denies any neurologic, psychiatric, or
autoimmune disease in the family.
On physical examination, the patient appeared comfortable, wellhydrated, and her vital signs were normal. Her examination
revealed no abnormalities, with the exception of hippus of the
pupils. Full neurologic examination was normal including visual
field testing with confrontational visual fields. Initial laboratory
examination revealed a mild microcytic anemia with a
hemoglobin of 11.9 g/dL and a normal chemistry panel including
a serum sodium of 139 meq/dL and creatinine of 0.5 mg/dL.

Differential Diagnosis and Evaluation
The most likely diagnoses given this patient’s history are diabetes
insipidus (DI) or psychogenic polydipsia. DI can be further
classified into nephrogenic or central. Nephrogenic DI is less likely
in this case as it generally occurs either as a genetic disease
presenting early in life in males or as a side effect of medications
such as lithium or demeclocyline. It may also be secondary to
hypercalcemia, which was normal on her laboratory evaluation.
Therefore, central DI and psychogenic polydipsia were the
remaining likely diagnoses. Both of these disorders are common to
the patient’s demographic. Central DI is caused by destruction of
the vasopressin producing cells in the posterior pituitary gland. It
is most often an idiopathic phenomenon likely to be autoimmune,
but other causes include infiltrative disorders such as hemochro-

44

matosis and sarcoidosis, as well as pituitary neoplasms. Psychogenic
polydipsia is also idiopathic and is thought to be caused by
dysfunction of thirst-regulating nuclei in the hypothalamus. It is
often associated with patients who have a psychiatric disorder but
can occur with infiltrative disorders and in otherwise normal
patients. Psychogenic polydipsia differs from DI in that patients
are driven to drink water and they urinate to compensate for the
increased volume load whereas in DI patients cannot concentrate
their urine and must drink to replace the lost fluids.1
The primary method to distinguish between these three disorders
is the water deprivation test. In this test, the patient remains NPO
and urine osmolarity is measured every hour. Additionally, the
serum osmolarity and sodium level are measured every 2 hours.
The test is stopped if the patient’s urine is concentrated to a level
of 600 mOsm in which case DI is ruled out. If the serum
osmolarity exceeds 295 mOsm or the urine osmolarity is stable
for 2-3 consecutive hours (less than 10% increase) while the serum
osmolarity is rising, DI is the likely diagnosis. At this point, 5 10 mcg of vasopressin is injected subcutaneously and the urine
osmolarity is measured one hour later. If the urine osmolarity
increases by 50% or more, the patient is considered to have central
DI. In many cases of central DI, the disease is only partial and
can be diagnosed if the urine osmolarity increases by 15-50%.1 If
the patient has nephrogenic DI, the urine osmolarity should not
significantly increase.
In addition to water deprivation test, MRI of the brain should be
obtained to rule out any obvious causes of central DI such as a
mass. In idiopathic central DI, the characteristic finding on MRI
is loss of the pituitary bright spot and thickening of the pituitary
stalk. If central DI is determined, a pituitary panel should be
obtained to rule out any other pituitary dysfunction.
The results of the water deprivation test in this patient are shown
in Table 1. The patient was unable to concentrate her urine greater
than 250 mOsm at 6 hours even though her serum osmolarity
rose to 297 mOsm after 4 hours. This indicated that she had
diabetes insipidus rather than psychogenic polydipsia. She was
given 5 mcg of subcutaneous vasopressin and her urine osmolarity
rose to 349 mOsm. Although this did not fulfill the 50% increase
requirement, it did surpass the 15% requirement for partial
central DI. With the high pretest likelihood of central DI rather
than nephrogenic DI, it was felt that she had partial central DI.
Interestingly, the patient reported a complete resolution of her
symptoms of thirst following administration of vasopressin. In
addition, MRI revealed loss of the posterior hypophyseal bright
spot and thickening of the pituitary stalk consistent with central
DI. She was started on 10 mcg of nasal desmopressin twice daily
and discharged the next day with instructions to obtain outpatient
blood work to monitor her electrolytes in one week and follow
up with the endocrinologist in 2 weeks. A pituitary panel was
drawn during the hospital stay with the results to be followed by
her endocrinologist.
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Table 1. Water deprivation test
Time
Na (mmol/L)
Serum osmolarity (mOsm)
Urine osmolarity
(mOsm)
2

8:00
142

105

9:00

202

10:00
141
294

11:00

288

269

12:00

13:00

14:00*

15:00

250

349

297

* 5 mcg vasopressin administered at this time.

Discussion
Idiopathic DI accounts for 30-50% of cases of central DI.2
Autoimmunity is thought to be an important cause of idiopathic
central DI. Pivonello et al. found that patients with idiopathic
central DI were significantly more likely than control patients to
display antibodies to arginine vasopressin-secreting cells. Age less
than 30, known autoimmune disease, and radiological evidence
of pituitary stalk thickening were all independent risk factors for
having a positive antibody assay. A patient with idiopathic DI and
all of these criteria has a 99% chance of having these antibodies.3
This patient had two of these parameters, which placed her at an
80% chance of having these autoimmune antibodies. While there
is no definitive proof that these antibodies are the cause of central
DI, this is a plausible explanation given our understanding of
autoimmunity.

To our knowledge, there are no known case reports of an
association between vaginal yeast infections or fluconazole and
central diabetes insipidus. The coincidental timing and likely
autoimmunity of this patient’s disease may suggest either the yeast
infection or fluconazole treatment as a possible trigger for the
disease. Although this represents only one case of central DI
following a vaginal yeast infection with fluconazole treatment,
further such reports might allow researchers to study and
understand this interesting disease.
■
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